Artículos de revistas
Consensus on prostate cancer treatment of localized disease with very low, low, and intermediate risk: A report from the first prostate cancer consensus conference for developing countries (PCCCDC)
Fecha
2021Registro en:
JCO Global Oncol 7:523-529 (2021)
10. 1200/GO.20.00515
Autor
De Almeida Luz, Murilo
Cardoso Guimarães, Gustavo
Nardi, Aguinaldo César
Feres Lima Pompeo, Alexandre Saad
Sadek Sarkis, Álvaro
Nowier, Amr
Lima Pompeo, Antonio Carlos
Nardozza Jr, Archimedes
Adamy Jr, Ari
Carneiro, Arie
Peres Salvajoli, Bernardo
Benigno, Bruno Santos
De Freitas Jr, Celso Heitor
Daher Cezar Chade, Clarissa Angotti
Freitas Palhares, Daniel Moore
Citarella Otero, Danilo Armando
Vieira da Silva Neto, Deusdedit Cortéz
Carvalhal, Eduardo Franco
Gil, Erlon
De Arruda, Fernando Freire
Korkes, Fernando
Lemos, Gustavo Caserta
Carvalhal, Gustavo Franco
De Carvalho, Icaro Thiago
Pinto Gimpel, Iván Federico
Chambô, José Luis
Pontes Jr, José
Ribeiro Filho, Leopoldo Alves
Nogueira, Lucas Mendes
Wroclawski, Marcelo Langer
Pereira Freitas, Marcelo Roberto
Arap, Marco Antônio
Sadi, Marcus Vinícius
Bulbul, Muhammad
Coelho, Rafael Ferreira
Gadia, Rafael
Khauli, Raja B.
Dos Reis, Rodolfo Borges
Ledezma Rojas, Rodrigo Antonio
Guimarães, Roger Guilherme
Aldousari, Saad
Ferrigno, Robson
Institución
Resumen
PURPOSE A group of international urology and medical oncology experts developed and completed a survey on
prostate cancer (PCa) in developing countries. The results are reviewed and summarized, and recommendations
on consensus statements for very low-, low-, and intermediate-risk PCa focused on developing countries
were developed.
METHODS A panel of experts developed more than 300 survey questions of which 66 questions concern the
principal areas of interest of this paper: very low, low, and intermediate risk of PCa in developing countries. A
larger panel of 99 international multidisciplinary cancer experts voted on these questions to create the recommendations
for treatment and follow-up for very low-, low-, and intermediate-risk PCa in areas of limited
resources discussed in this manuscript.
RESULTS The panel voted publicly but anonymously on the predefined questions. Each question was deemed
consensus if 75% or more of the full panel had selected a particular answer. These answers are based on
panelist opinion not a literature review or meta-analysis. For questions that refer to an area of limited resources,
the recommendations consider cost-effectiveness and the possible therapies with easier and greater access.
Each question had five to seven relevant answers including two nonanswers. The results were tabulated in real
time.
CONCLUSION The voting results and recommendations presented in this document can be used by physicians to
support management for very low, low, and intermediate risk of PCa in areas of limited resources. Individual
clinical decision making should be supported by available data; however, as guidelines for treatment for very low,
low, and intermediate risk of PCa in developing countries have not been developed, this document will serve as a
point of reference when confronted with this disease.